Credit Suisse’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-41,400
Closed -$10.6M 3912
2021
Q4
$10.6M Buy
41,400
+23,600
+133% +$5.77M 0.01% 1464
2021
Q3
$4.32M Buy
17,800
+1,300
+8% +$318K ﹤0.01% 2189
2021
Q2
$3.4M Hold
16,500
﹤0.01% 2420
2021
Q1
$3.11M Sell
16,500
-21,100
-56% -$3.72M ﹤0.01% 2491
2020
Q4
$6.18M Hold
37,600
﹤0.01% 1930
2020
Q3
$4.69M Buy
37,600
+28,200
+300% +$3.49M ﹤0.01% 1837
2020
Q2
$912K Hold
9,400
﹤0.01% 2964
2020
Q1
$845K Buy
+9,400
New +$1.22M ﹤0.01% 2790
2017
Q2
Sell
-19,800
Closed -$1.76M 3877
2017
Q1
$1.76M Buy
+19,800
New +$1.65M ﹤0.01% 2438
2015
Q1
Sell
-50,000
Closed -$3.67M 4450
2014
Q4
$3.67M Buy
+50,000
New +$3.51M ﹤0.01% 2021
2014
Q1
Sell
-16,800
Closed -$802K 4740
2013
Q4
$802K Buy
+16,800
New +$776K ﹤0.01% 3458

Other funds holding HCA

Credit Suisse's HCA Position: Q1 2024 in Review

Credit Suisse reduced its HCA Healthcare (HCA) stake by 5.1% in Q1 2024, selling an estimated $5.04M and leaving 306,195 shares worth $102M. The position accounts for 0.1% of the portfolio, ranked #195.

Credit Suisse first reported a position in HCA in Q2 2013 and has held it in 44 quarters since. The position peaked at $119M in Q2 2022. 1,126 funds tracked by Wall St. Rank hold HCA as of Q1 2024.

  • Credit Suisse held 306,195 shares of HCA Healthcare worth $102M as of Q1 2024.
  • Credit Suisse sold 16,504 HCA Healthcare shares in Q1 2024, an estimated $5.04M.
  • HCA Healthcare made up 0.1% of Credit Suisse's portfolio in Q1 2024, its #195 holding.
  • Credit Suisse first reported a position in HCA Healthcare in Q2 2013 and has held it in 44 quarters since.
  • Credit Suisse's HCA Healthcare position peaked at $119M in Q2 2022.
  • 1,126 funds tracked by Wall St. Rank held HCA Healthcare as of Q1 2024.

Based on Credit Suisse's 13F filing for Q1 2024, filed 10 May 2024.